Comparison of two blood pool contrast agents for 0.5-T MR angiography: Experimental study in rabbits

Radiology

Volumn 214, Issue 3, 2000, Pages 787-794

  Clarke, Sharon E ^a,b   Weinmann, Hanns Joachim ^c   Dai, Erbin ^a   Lucas, Alexandra R ^a   Rutt, Brian K ^a,b  

^a ROBARTS RESEARCH INSTITUTE   (Canada)

^b UNIVERSITY OF WESTERN ONTARIO   (Canada)

^c BAYER PHARMA AG   (Germany)

Author keywords

Contrast media, comparative studies; Contrast media, experimental studies; Gadolinium; Iron; Magnetic resonance (MR), contrast media; Magnetic resonance (MR), vascular studies

Indexed keywords

GADOLINIUM; GADOLINIUM PENTETATE MEGLUMINE; IRON OXIDE;

ABDOMINAL AORTA; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTRAST ENHANCEMENT; CONTROLLED STUDY; IMAGE INTENSIFIER; KIDNEY CLEARANCE; MAGNETIC RESONANCE ANGIOGRAPHY; MALE; NONHUMAN; PRIORITY JOURNAL; RABBIT; RESPONSE TIME; SIGNAL NOISE RATIO;

EID: 0034052192     PISSN: 00338419     EISSN: None     Source Type: Journal    
DOI: 10.1148/radiology.214.3.r00mr25787     Document Type: Article

References (25)

1. Snidow JJ, Aisen AM, Harris VJ, et al. Iliac artery MR angiography: comparison of three-dimensional gadolinium-enhanced and two-dimensional time-of-flight techniques. Radiology 1995; 196:371-378.
2. Maki JH, Chenevert TL, Prince MR. Contrast-enhanced MR angiography. Abdom Imaging 1998; 23:469-484.
3. Parker DL, Tsuruda JS, Goodrich KC, Alexander AL, Buswell HR. Contrast-enhanced magnetic resonance angiography of cerebral arteries: a review. Invest Radiol 1998; 33:560-572.
4. Prince MR, Narasimham DL, Stanley JC, et al. Breath-hold gadolinium-enhanced MR angiography of the abdominal aorta and its major branches. Radiology 1995; 197:785-792.
5. Dong Q, Hurst DR, Weinmann HJ, Chenevert TL, Londy FJ, Prince MR. Magnetic resonance angiography with Gadomer-17: an animal study original investigation. Invest Radiol 1998; 33:699-708.
6. Wang SC, Wikstrom MG, White DL, et al. Evaluation of Gd-DTPA-labeled dextran as an intravascular MR contrast agent: imaging characteristics in normal rat tissues. Radiology 1990; 175:483-488.
7. Marchal G, Bosmans H, Van Hecke P, et al. MR angiography with gadopentetate dimeglumine-polylysine: evaluation in rabbits. AJR Am J Roentgenol 1990; 155: 407-411.
8. Mayo-Smith WW, Saini S, Slater G, Kaufman JA, Sharma P, Hahn PF. MR contrast material for vascular enhancement: value of superparamagnetic iron oxide. AJR Am J Roentgenol 1996; 166:73-77.
9. Nolte-Ernsting C, Adam G, Bucker A, Berges S, Bjornerud A, Gunther RW. Abdominal MR angiography performed using blood pool contrast agents: comparison of a new superparamagnetic iron oxide nanoparticle and a linear gadolinium polymer. AJR Am J Roentgenol 1998; 171:107-113.
10. Frank H, Weissleder R, Brady TJ. Enhancement of MR angiography with iron oxide: preliminary studies in whole-blood phantom and in animals. AJR Am J Roentgenol 1994; 162:209-213.
11. Koenig SH, Kellar KE. Theory of 1/T1 and 1/T2 NMRD profiles of solutions of magnetic nanoparticles. Magn Reson Med 1995; 34:227-233.
12. Adam G, Neuerburg J, Spuntrup E, Muhler A, Scherer K, Gunther RW. Gd-DTPA-cascade-polymer: potential blood pool contrast agent for MR imaging. J Magn Reson Imaging 1994; 4:462-466.
13. Wiener EC, Brechbiel MW, Brothers H, et al. Dendrimer-based metal chelates: a new class of magnetic resonance imaging contrast agents. Magn Reson Med 1994; 31: 1-8.
14. Kopp AF, Laniado M, Dammann F, et al. MR imaging of the liver with Resovist: safety, efficacy, and pharmacodynamic properties. Radiology 1997; 204:749-756.
15. Vogl TJ, Hammerstingl R, Schwarz W, et al. Magnetic resonance imaging of focal liver lesions: comparison of the superparamagnetic iron oxide Resovist versus gadolinium-DTPA in the same patient. Invest Radiol 1996; 31:696-708.
16. Reimer P, Schuierer G, Balzer T, Peters PE. Application of a superparamagnetic iron oxide (Resovist) for MR imaging of human cerebral blood volume. Magn Reson Med 1995; 34:694-697.
17. Lawaczeck R, Bauer H, Frenzel T, et al. Magnetic iron oxide particles coated with carboxydextran for parenteral administration and liver contrasting: pre-clinical profile of SH U555A. Acta Radiol 1997; 38(4 pt 1):584-597.
18. Loubeyre P, Canet E, Zhao S, Benderbous S, Amiel M, Revel D. Carboxymethyldextran-gadolinium-DTPA as a bloodpool contrast agent for magnetic resonance angiography: experimental study in rabbits. Invest Radiol 1996; 31:288-293.
19. Roberts HC, Saeed M, Roberts TP, et al. Comparison of albumin-(Gd-DTPA)30 and Gd-DTPA-24-cascade-polymer for measurements of normal and abnormal microvascular permeability. J Magn Reson Imaging 1997; 7:331-338.
20. Van Hecke P, Marchal G, Bosmans H, et al. NMR imaging study of the pharmacodynamics of polylysine-gadolinium-DTPA in the rabbit and the rat. Magn Reson Imaging 1991; 9:313-321.
21. Marchal G, Bosmans H, Van Hecke P, Jiang YB, Aerts P, Bauer H. Experimental Gd-DTPA polylysine enhanced MR angiography: sequence optimization. J Comput Assist Tomogr 1991; 15:711-715.
22. Engelbrecht MR, Saeed M, Wendland MF, Canet E, Oksendal AN, Higgins CB. Contrast-enhanced 3D-TOF MRA of peripheral vessels: intravascular versus extracellular MR contrast media. J Magn Reson Imaging 1998; 8:616-621.
23. Li D, Dolan RP, Walovitch RC, Lauffer RB. Three-dimensional MRI of coronary arteries using an intravascular contrast agent. Magn Reson Med 1998; 39:1014-1018.
24. Adam G, Muhler A, Spuntrup E, et al. Differentiation of spontaneous canine breast tumors using dynamic magnetic resonance imaging with 24-gadolinium-DTPA-cascade-polymer, a new blood-pool agent: preliminary experience. Invest Radiol 1996; 31:267-274.
25. Schwickert HC, Roberts TP, Muhler A, Stiskal M, Demsar F, Brasch RC. Angiographic properties of Gd-DTPA-24-cascade-polymer: a new macromolecular MR contrast agent. Eur J Radiol 1995; 20:144-150.